Tag - biotech

From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand

Stop Guessing. Start Diagnosing: The Marketing & Product-Market Fit Scorecard

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

Customer Testimonials

Most Life Science Startups Hire Too Small. Here’s Why That’s a Costly Mistake

Neither AI nor ChatGPT Will Save Your Drug Discovery Pipeline …

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

How Marketing Automation Effectively Tracks Lead Acquisition Attribution

AGBT 2025 – And the Winner is, Drum Roll, Sequencing

TLDR; The Value of Drugs for Rare Disease Indications May Be Higher Than You Think – Assets for Neurodevelopmental Disorders Alone May Be Worth Beyond USD $420B.

2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….

We Invite you to join enlightenbio’s Subject Matter Expert Network!

Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials

Genomics England launches next-generation research platform central to UK COVID-19 response

Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment

Copyright © 2026. enlighenbio LLC. All rights reserved.